By proceeding, you agree to our Terms of Use and Privacy Policy.
Physiogenex is a leading preclinical contract research organization (CRO) specializing in metabolic disorders such as diabetes, obesity, liver diseases, dyslipidemia, atherosclerosis and cardiovascular complications.
25-27 January 2022
The HFpEF Drug Discovery & Development Summit 2022 is the first industry-specific forum exclusively focused on showcasing the latest drug development and translational research in HFpEF and its relationship with metabolic syndromes and co-morbidities
Event Ended
Virtual
Paid
09-11 November 2022
Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF, NASH, CKD and more in one place at one time, so you can advance the progress of your antifibrotic therapies.
USA
Boston
29-01 December 2022
Welcome to the 6th Obesity & NASH Drug Development Summit There has been a rise and fall of investment in NASH in the wake of highly demanding biopsy endpoints and late-stage clinical setbacks.
24-26 January 2023
Welcome to the 2nd HFpEF & HCM Drug Discovery & Development Summit The Industry's Only Definitive Forum for Cardiovascular Drug Discovery & Development Cardiovascular stakeholders are racing to answer the burning questions limiting them from capitali